These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 2926326)

  • 1. Interferon alpha associated with systemic lupus erythematosus is not intrinsically acid labile.
    Yee AM; Buyon JP; Yip YK
    J Exp Med; 1989 Mar; 169(3):987-93. PubMed ID: 2926326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum activity that confers acid lability to alpha-interferon in systemic lupus erythematosus: its association with disease activity and its independence from circulating alpha-interferon.
    Yee AM; Yip YK; Fischer HD; Buyon JP
    Arthritis Rheum; 1990 Apr; 33(4):563-8. PubMed ID: 2328034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human acid-labile interferon alpha.
    Piasecki E
    Arch Immunol Ther Exp (Warsz); 1999; 47(2):89-98. PubMed ID: 10202561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between circulating interferon and anti-interferon antibodies and impaired natural killer cell activity in systemic lupus erythematosus.
    Sibbitt WL; Gibbs DL; Kenny C; Bankhurst AD; Searles RP; Ley KD
    Arthritis Rheum; 1985 Jun; 28(6):624-9. PubMed ID: 2408630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MX homologous protein in mononuclear cells from patients with systemic lupus erythematosus.
    von Wussow P; Jakschies D; Hochkeppel H; Horisberger M; Hartung K; Deicher H
    Arthritis Rheum; 1989 Jul; 32(7):914-8. PubMed ID: 2751723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Higher activation of the interferon-gamma signaling pathway in systemic lupus erythematosus patients with a high type I IFN score: relation to disease activity.
    Liu M; Liu J; Hao S; Wu P; Zhang X; Xiao Y; Jiang G; Huang X
    Clin Rheumatol; 2018 Oct; 37(10):2675-2684. PubMed ID: 29774490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Presence of interferon and anti-interferon in patients with systemic lupus erythematosus.
    von Wussow P; Jakschies D; Hartung K; Deicher H
    Rheumatol Int; 1988; 8(5):225-30. PubMed ID: 3266358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Type I interferon-mediated skewing of the serotonin synthesis is associated with severe disease in systemic lupus erythematosus.
    Lood C; Tydén H; Gullstrand B; Klint C; Wenglén C; Nielsen CT; Heegaard NH; Jönsen A; Kahn R; Bengtsson AA
    PLoS One; 2015; 10(4):e0125109. PubMed ID: 25897671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interferon-induced 2'-5' adenylate synthetase in vivo and interferon production in vitro by lymphocytes from systemic lupus erythematosus patients with and without circulating interferon.
    Preble OT; Rothko K; Klippel JH; Friedman RM; Johnston MI
    J Exp Med; 1983 Jun; 157(6):2140-6. PubMed ID: 6189954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FCgammaRII (CD32)-dependent induction of interferon-alpha by serum from patients with lupus erythematosus.
    Batteux F; Palmer P; Daëron M; Weill B; Lebon P
    Eur Cytokine Netw; 1999 Dec; 10(4):509-14. PubMed ID: 10586117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interferon-α coincides with suppressed levels of pentraxin-3 (PTX3) in systemic lupus erythematosus and regulates leucocyte PTX3 in vitro.
    Wirestam L; Enocsson H; Skogh T; Eloranta ML; Rönnblom L; Sjöwall C; Wetterö J
    Clin Exp Immunol; 2017 Jul; 189(1):83-91. PubMed ID: 28257596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Peripheral blood mRNA and interferon gene expression in systemic lupus erythematosus].
    Tang JP; Gu YY; Shen N; Qian J; Chen XX; Huang XF; Huang XY; Liang D; Guo Q; Yang CD; Bao CD; Chen SL
    Zhonghua Nei Ke Za Zhi; 2005 Feb; 44(2):106-10. PubMed ID: 15840221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum alpha interferon and lymphocyte inclusions in systemic lupus erythematosus.
    Klippel JH; Carette S; Preble OT; Friedman RM; Grimley PM
    Ann Rheum Dis; 1985 Feb; 44(2):104-8. PubMed ID: 2983625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Type I interferon and T helper 17 cells co-exist and co-regulate disease pathogenesis in lupus patients.
    Biswas PS; Aggarwal R; Levesque MC; Maers K; Ramani K
    Int J Rheum Dis; 2015 Jul; 18(6):646-53. PubMed ID: 25960196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [alpha-Interferon indices in systemic lupus erythematosus and the effect of interferon therapy].
    Barinskiĭ IF; Alekberova ZS; Savinov VA; Pitenov VA; Kuznetsov VP
    Vopr Virusol; 1983; 28(6):733-6. PubMed ID: 6670258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endogenous type-I interferon activity is not associated with depression or fatigue in systemic lupus erythematosus.
    Kellner ES; Lee PY; Li Y; Switanek J; Zhuang H; Segal MS; Sobel ES; Satoh M; Reeves WH
    J Neuroimmunol; 2010 Jun; 223(1-2):13-9. PubMed ID: 20416954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic lupus erythematosus: presence in human serum of an unusual acid-labile leukocyte interferon.
    Preble OT; Black RJ; Friedman RM; Klippel JH; Vilcek J
    Science; 1982 Apr; 216(4544):429-31. PubMed ID: 6176024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interferon alpha gene expression and serum level association with low vitamin D levels in Egyptian female patients with systemic lupus erythematosus.
    Abdel Galil SM; El-Shafey AM; Abdul-Maksoud RS; El-Boshy M
    Lupus; 2018 Feb; 27(2):199-209. PubMed ID: 28659049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Acid-labile alpha interferon produced by peripheral blood mononuclear cells stimulated by cells infected by HIV].
    Dianzani F; Capobianchi MR; De Marco F; Di Marco P; Gentile M; Antonelli G; Amicucci P; Cefaro A; Ruggiero V; Turriziani O
    Ann Ig; 1989; 1(3-4):647-60. PubMed ID: 2483637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of glycosilation in the susceptibility of "acid labile" interferon alpha to acid treatment.
    Capobianchi MR; Mattana P; Gentile M; Conciatori GC; Ankel H; Dianzani F
    J Biol Regul Homeost Agents; 1991; 5(4):147-53. PubMed ID: 1803862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.